Publications

Nwosu BUdoka, Parajuli S, Jasmin G, Fleshman J, Sharma RB, Alonso LC, Lee AF, Barton BA.  2022.  Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial.. J Endocr Soc. 6(1):bvab179.

Nwosu BUdoka, Yeasmin S, Ayyoub S, Rupendu S, Villalobos-Ortiz TR, Jasmin G, Parajuli S, Zahedi B, Zitek-Morrison E, Alonso LC et al..  2020.  Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.. J Pediatr Endocrinol Metab. 33(7):865-872.

Nwosu BUdoka, Zhang B, Ayyoub SS, Choi S, Villalobos-Ortiz TR, Alonso LC, Barton BA.  2018.  Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.. PLoS One. 13(5):e0196912.

Lundberg RL, Marino KR, Jasrotia A, Maranda LS, Barton BA, Alonso LC, Nwosu BUdoka.  2017.  Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.. J Pediatr Endocrinol Metab. 30(8):823-830.

Marino KR, Lundberg RL, Jasrotia A, Maranda LS, Thompson MJ, Barton BA, Alonso LC, Nwosu BUdoka.  2017.  A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.. PLoS One. 12(5):e0176860.